Due to its strong and growing commitment to the life sciences industry, Marlborough is rated a Platinum BioReady Community by the Massachusetts Biotechnology Council (MassBio). This puts the city among the most favorable biotech destinations in the state–just 7% of Massachusetts communities have achieved “Platinum” status.
In 2013, MassBio’s President and CEO Robert Coughling went a step further, when he hailed Marlborough as a “key biotechnology hub in the Commonwealth of Massachusetts.” That’s because about 30 life sciences companies already call this city home, and that number is growing every year. In 2014 alone, Marlborough will welcome the new headquarters of medical devices giant Boston Scientific, and the regional “Hub Lab” of testing services leader Quest Diagnostics.
In order to achieve a BioReady ranking, a municipality must:
- Allow biotech laboratory and manufacturing uses by right
- Identify buildings / land sites for biotechnology uses in municipal plans
- Convene site plan review meetings to provide an overview of the local approvals process for significant commercial and industrial projects
- Have land sites / buildings included in MassEcon’s BioSites inventory
- Have pre-permitted sites / buildings for biotechnology laboratory or manufacturing use
- Have existing buildings where biotech laboratory or manufacturing activities are taking place
In addition to the above, at the Platinum level, municipalities must have #1 and #2, or #3 of the following:
- The municipality’s Board of Health has adopted the National Institutes of Health guidelines on rDNA activity as part of its regulations.
- The municipality includes a building or buildings that are already permitted for biotech uses and have 20,000 square feet or more of available space for biotech uses.
- The municipality has a shovel-ready pre-permitted land site with completed MEPA review and municipal water and sewer capacity to meet additional demand.
For more information about the BioReady™ ratings, visit: www.massbio.org.